Deprescribing: Achieving Better Health Outcomes for Older People Through Reducing Medications

Journal of Pharmacy Practice and Research

Volumn 33, Issue 4, 2003, Pages 323-328

  Woodward, Michael C ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMANTADINE; AMINOPHYLLINE; AMITRIPTYLINE; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; BARBITURIC ACID DERIVATIVE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROMAZINE; CHLORPROPAMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXTROPROPOXYPHENE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOSULEPIN; DOXEPIN; FLUNITRAZEPAM; GLIBENCLAMIDE; GLIMEPIRIDE; INDOMETACIN; LOOP DIURETIC AGENT; METHYLDOPA; NITRAZEPAM; PIROXICAM; THIAZIDE DIURETIC AGENT; TRIHEXYPHENIDYL; UNINDEXED DRUG;

CONFUSION; DEMENTIA; DRUG COST; DRUG INDICATION; DRUG MONITORING; DRUG WITHDRAWAL; EDEMA; ELDERLY CARE; GOUT; HEART FAILURE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MEMORY DISORDER; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PHARMACIST; POLYPHARMACY; PRESCRIPTION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; TREATMENT PLANNING; URINE RETENTION; WITHDRAWAL SYNDROME;

EID: 0347993031     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2003334323     Document Type: Review

References (60)

1. The Australian Institute of Health and Welfare. Australia's Health 2000: the seventh biennial report of the Australian Institute of Health and Welfare. Canberra: The Australian Institute of Health and Welfare; 2000.
2. Le Couteur DG, Johnson AG. Drugs and the elderly: prescription idiosyncrasies. Mod Med Aust 1997; 40: 30-7.
3. Macklin J. Issues in pharmaceutical drug use in Australia. Canberra: Treble Press; 1992.
4. Roberts MS, King M, Stokes JA, Lynne T, Bonner C, McCarthy S, et al. Medication prescribing and administration in nursing homes. Age Ageing 1998; 27: 385-92.
5. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205.
6. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-8.
7. Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J 1999; 92: 485-90.
8. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701-7.
9. Col N, Fanale JC, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5.
10. Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161: 1629-34
11. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-8.
12. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-9.
13. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 40-50.
14. Woodward MC. Hypnosedatives in the elderly. A guideline to appropriate use. CNS Drugs 1999; 11: 263-77.
15. Hulka BS, Kupper LL, Cassel JC, Efird RL. Medication use and misuse: physician-patient discrepancies. J Chronic Disease 1975; 28: 7-21.
16. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-6.
17. Shelton PS, Fritsch MA, Scott MA. Assessing medication appropriateness in the elderly. A review of available measures. Drugs Aging 2000; 16: 437-50.
18. Oborne CA, Batty GM, Maskrey V, Swift CG, Jackson SHD. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91-7.
19. Elliott RA, Woodward MC, Oborne CA. Indicators of prescribing quality for elderly hospital patients. Aust J Hosp Pharm 2001; 31: 19-25.
20. Elliott RA, Woodward MC, Oborne CA. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern Med J 2001; 31: 529-35.
21. Elliott RA, Woodward MC, Oborne CA. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feeback to improve prescribing. Age Ageing 2002; 21: 391-6.
22. Kelly J, Chamber J. Inappropriate use of loop diuretics in elderly patients. Age Ageing 2000; 29: 489-93.
23. Roe CM, Anderson MJ, Spivack B. Use of anticholinergic medications by older adults with dementia. J Am Geriatr Soc 2002; 50: 836-42.
24. Golden AG, Preston RA, Barnett SD, Llorente M, Hamdan K, Silverman MA. Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc 1999; 47: 948-53.
25. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200-9.
26. Hanlon JT, Schmader KE, Boult C, Artz MB, Gross CR, Fillenbaum GC, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 2002; 50: 26-34.
27. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272: 292-6.
28. Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC. Inappropriate medication use in community-residing older people. Arch Intern Med 1994; 154: 2195-200.
29. Giron MST, Wang H-X, Bernston C, Thorslund M, Winblad B, Fastbom J. The appropriateness of drug use in an older non-demented and demented population. J Am Geriatr Soc 2001; 49: 277-83.
30. Krska J, Cromaty JA, Arris F, Jamieson D, Hansford D, Duffies PRS, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trail in primary care. Age Ageing 2001; 30: 205-11.
31. Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug-related problems in an outpatient haemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997; 47: 117-21.
32. Lowe CJ, Raynor DK, Purvis S, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50: 172-5.
33. Burns R, Nichols LO, Graney MJ, Cloar FT. Impact of continued geriatric outpatient management on health outcomes of older veterans. Arch Intern Med 1995; 155: 1313-8.
34. Toseland RW, O'Donnell JC, Engelhardt SB, Hendler SA, Ritchie JT, Jue D. Outpatient geriatric evaluation and management. Results of a randomized trial. Med Care 1996; 34: 624-40.
35. Fijn R, Brouwers JR, Timmer JM, de Jong-van den Berg LT. Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines. Pharm World Sci 2000; 22: 152-8.
36. Nilsson G, Hjemdahl P, Hassler A, Vitol S, Wallen NH, Krakau I. Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners. Eur J Clin Pharmacol 2001; 56: 843-8.
37. May FW, Rowell DS, Gilbert AL, McNeece JI, Hurley E. Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. Med J Aust 1999; 170: 471-4.
38. Kocken GA. Medication discussion groups in the Netherlands: five years of experience. Med Educ 1999; 33: 390-3.
39. Stein CM, Griffin MR, Taylor JA, Pichert JW, Brandt KA, Ray WA. Educational progress for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial. Med Care 2001; 39: 436-45.
40. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
41. Gosh S, Ziesmer V, Aronow WS. Underutilization of aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs, and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home. J Gerontol Series B - Biol Sciences and Med Sciences 2002; 57: M398-400.
42. McClean WJ, Higginbotham NH. Prevalence of pain amongst nursing home residents in rural New South Wales. Med J Aust 2003; 177: 17-20.
43. Woodward MC, Streeton C, Henshaw K, Killer G, Peck R. Reducing prescribing of long-acting benzodiazepines in large community veteran population [abstract]. Proceedings of the European Regional Meeting of the International Psychogeriatric Association 2003: 64.
44. Elliott RA, Thomson WA. Assessment of a nursing home medication review service provided by hospital-based clinical pharmacists. Aust J Hosp Pharm 1999; 29: 255-60.
45. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonerbgan TP, Schaiff RA, et al. A prospective randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999; 159: 2306-9.
46. Khunti K, Kinsella B. Effect of a systematic review of medications by general practitioner on drug consumption among nursing home residents. Age Ageing 2000; 29: 451-3.
47. Nelson MR, Reid CM, Krum H, Muir T, Ryan P, McNeil JJ. Prediction of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort. BMJ 2002; 325: 815-9.
48. Woodward MC. Hypnotics. Options to help your patients stop. Aust Fam Phys 2000; 29: 1-6.
49. Graves T, Hanlon JT, Schmader KE, Landsman PB, Samsa GP, Pieper CF, et al. Adverse events after discontinuing medication in elderly outpatients. Arch Intern Med 1997; 157: 2205-10.
50. Al Mahdy H, Seymour DG. How much can elderly patients tell us about their medications? Postgrad Med J 1990; 66: 116-21.
51. Bibowski RM, Ripsin CM, Lorraine VL. Physician-patient congruence regarding medication regimens. J Am Geriatr Soc 2001; 49: 1353-7.
52. Aitkin PA, Stringer RS, Duffy JB, Elion C, Ferraris CS, Misrachi SR, et al. The influence of information provided by patients on the accuracy of medication records. Med J Aust 1998; 169: 85-8.
53. Aitkin PA, Shenfield GM. How many medications do elderly patients really take? Aust J Hosp Pharm 1993; 23: 109-13.
54. Lim WK, Mason J. The importance of home visits: a case of extreme polypharmacy. Australasian Journal on Ageing 2000; 19: 94-5.
55. Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA. The impact of specialists on prescribing by general practitioners. Med J Aust 2001; 175: 407-11.
56. Mannesse CK, Derkx FHM, De Ridder MAJ. Man in 't Veld AJ, Van der Cammen TJM. Do older hospital patients recognize adverse drug reactions? Age Ageing 2000; 29: 79-81.
57. Parsa MA, Greenaway HM, Bastani B. Treatment of psychosis in patients with Parkinson's disease and dementia (Lewy Body disease variant) with quetiapine [abstract plus oral presentation]. Proceedings of the 52nd Annual Meeting of the American Academy of Neurology; 2000 Apr 29-May 6; San Diego, California. Saint Paul: American Academy of Neurology; 2000. p. A451-2.
58. Metheson AJ, Lamb HM. Quetiapine: a review of its clinical potential in the management of psychotic symptoms in Parkinson's Disease. CNS Drugs 2000; 14: 157-72.
59. Pushpangadan M, Feely M. Once a day is best: evidence or assumption? The relationship between compliance and dosage frequency in older people. Drugs Aging 1998; 13: 223-6.
60. Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ 2000; 320: 484-8.